Clinical Trial Update: A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)

View source ↗

Summary

Takeda-sponsored trial evaluating a treatment for moderate-to-severe inflammatory bowel disease, including ulcerative colitis and Crohn's disease, has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Snippet

Sponsor: Takeda | Conditions: Inflammatory Bowel Diseases, Colitis, Ulcerative | Status: COMPLETED | Results posted: 2024-11-07